Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.
2.

First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer.

Dudek AZ, Yunis C, Harrison LI, Kumar S, Hawkinson R, Cooley S, Vasilakos JP, Gorski KS, Miller JS.

Clin Cancer Res. 2007 Dec 1;13(23):7119-25.

3.
4.

Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans.

Chau AS, Gurnani M, Hawkinson R, Laverdiere M, Cacciapuoti A, McNicholas PM.

Antimicrob Agents Chemother. 2005 Sep;49(9):3646-51.

5.

The effect of human immunodeficiency virus on endodontic treatment outcome.

Quesnell BT, Alves M, Hawkinson RW Jr, Johnson BR, Wenckus CS, BeGole EA.

J Endod. 2005 Sep;31(9):633-6.

PMID:
16123697
6.

Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection.

Allen MS, Wood DE, Hawkinson RW, Harpole DH, McKenna RJ, Walsh GL, Vallieres E, Miller DL, Nichols FC 3rd, Smythe WR, Davis RD; 3M Surgical Sealant Study Group.

Ann Thorac Surg. 2004 May;77(5):1792-801.

PMID:
15111188
7.

The effect of CO2 laser irradiation on PDL cell attachment to resected root surfaces.

Fayad MI, Hawkinson R, Daniel J, Hao J.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Apr;97(4):518-23.

PMID:
15088038
8.

Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.

Demedts M, Cohen R, Hawkinson R.

Int J Clin Pract. 1999 Jul-Aug;53(5):331-8.

PMID:
10695095
9.

Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.

Parker JO, Amies MH, Hawkinson RW, Heilman JM, Hougham AJ, Vollmer MC, Wilson RR.

Circulation. 1995 Mar 1;91(5):1368-74.

PMID:
7867175
10.

Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.

Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT Jr, Hawkinson RW, Pritchett EL.

Am Heart J. 1992 Aug;124(2):381-6.

PMID:
1636582
11.

Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.

Henthorn RW, Waldo AL, Anderson JL, Gilbert EM, Alpert BL, Bhandari AK, Hawkinson RW, Pritchett EL.

Circulation. 1991 Jan;83(1):119-25.

PMID:
1898640
13.

Adhesion-to-skin performance of a new transdermal nitroglycerin adhesive patch.

Wick KA, Wick SM, Hawkinson RW, Holtzman JL.

Clin Ther. 1989 May-Jun;11(3):417-24.

PMID:
2501033
14.

Drug release rates from four sizes of a new transdermal nitroglycerin adhesive patch.

Riedel DJ, Wick KA, Hawkinson RW, Kolars CA, Crowley JK, Harrison LI, de Dennis SR.

Clin Ther. 1989 May-Jun;11(3):409-16.

PMID:
2501032
15.

Performance of a new transdermal nitroglycerin adhesive patch formulation.

Riedel DJ, Wick KA, Hawkinson RW, Kolars CA, Crowley JK, Armstrong KE, Chang SF, Harrison LI, de Dennis SR.

Clin Ther. 1989 Mar-Apr;11(2):225-31.

PMID:
2500248
16.

Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery system.

Hougham AJ, Hawkinson RW, Crowley JK, Wilson RR, Glode JE, Hilty RW, Hughes SO, Koeppl CG, Kovaric TR, Wyskoarko NP.

Clin Ther. 1989;11(1):23-31.

PMID:
2497985
17.

Improved comfort and patient acceptance in a novel transdermal nitroglycerin delivery system.

Hougham AJ, Hawkinson RW, Crowley JK, Wilson RR, Brown SG, Dougherty PJ, Fogel MA, Hash VW Jr, Rietbrock MJ.

Clin Ther. 1989;11(1):15-22.

PMID:
2497982
18.

Influence of inoculum growth phase on microdilution susceptibility tests.

Barry AL, Badal RE, Hawkinson RW.

J Clin Microbiol. 1983 Sep;18(3):645-51.

19.
21.

Electron microscopy of dentinal tubule sclerosis in the enamel-free region of the rat molar.

Hawkinson RW, Eisenmann DR.

Arch Oral Biol. 1983;28(5):409-14.

PMID:
6578758
22.

Use of a teat sealer for prevention of intramammary infections in lactating cows.

Farnsworth RJ, Wyman L, Hawkinson R.

J Am Vet Med Assoc. 1980 Sep 1;177(5):441-4.

PMID:
7440342
23.

Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test.

Barry AL, Coyle MB, Thornsberry C, Gerlach EH, Hawkinson RW.

J Clin Microbiol. 1979 Dec;10(6):885-9.

24.

Simple inoculum standardizing system for antimicrobial disk susceptibility tests.

Barry AL, Amsterdam D, Coyle MB, Gerlach EH, Thornsberry C, Hawkinson RW.

J Clin Microbiol. 1979 Dec;10(6):910-8.

25.

Immediate permanent reconstruction of a mandibular continuity defect with use of a prosthesis of chromium-cobalt alloy.

Markowitz NR, Catone GA, Merrill R, Wolford DG, Hawkinson R.

J Am Dent Assoc. 1979 Jun;98(6):943-6.

PMID:
287714
26.

Genesis of the denturist: a study in apathy.

Hawkinson R.

J Mich Dent Assoc. 1978 Jul-Aug;60(7-8):427-9. No abstract available.

PMID:
385883
27.

The use of clomipramine in phobic patients. Preliminary research report.

Carey MS, Hawkinson R, Kornhaber A, Wellish CS.

Curr Ther Res Clin Exp. 1975 Jan;17(1):107-10. No abstract available.

PMID:
806423
28.

Retrognathia correction by means of an arcing osteotomy in the ascending ramus.

Hawkinson RT.

J Prosthet Dent. 1968 Jul;20(1):77-86. No abstract available.

PMID:
5241935
29.

Diagnosis and preoperative planning for the surgical correction of mandibular prognathism.

Hawkinson RT.

J Prosthet Dent. 1966 Mar-Apr;16(2):351-70. No abstract available.

PMID:
5217118
30.

Development of skin surface texture in maxillofacial prosthetics.

Hawkinson RT.

J Prosthet Dent. 1965 Sep-Oct;15(5):929-37. No abstract available.

PMID:
5212679

Supplemental Content

Loading ...
Support Center